De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring
Guillaume Moulis, Étienne Crickx, Laure Thomas, Nathalie Massy, Matthieu Mahévas, Marie‐Blanche Valnet‐Rabier, Marina Atzenhoffer, Marc Michel, Bertrand Godeau, Haleh Bagheri, Francesco Salvo, and the French Covigilance COVID-19 Vaccine-ITP Study Group
Abstract
International audience
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Immune thrombocytopeniaVirologyImmunologyHematologic Neoplasms2019-20 coronavirus outbreakAntibodyInternal medicineTransplantationOutbreakInfectious disease (medical specialty)DiseasePlatelet Disorders and TreatmentsHeparin-Induced Thrombocytopenia and ThrombosisBlood groups and transfusion